Veradermics (MANE) Equity Ratio (2024 - 2026)

Veradermics (MANE) has 3 years of Equity Ratio data on file, last reported at 0.98 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio changed N/A year-over-year to 0.98; the trailing twelve-month figure through Mar 2026 stood at 0.98 (changed N/A YoY), and the FY2025 full-year result was 0.79, up 9.17% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.98, up from 0.79 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.98 in Q1 2026 and bottomed at 0.87 in Q4 2024.
• The 3-year median for Equity Ratio is 0.79 (2025), against an average of 0.23.
• Peak annual rise in Equity Ratio reached 9.17% in 2025, while the deepest fall reached 9.17% in 2025.
• A 3-year view of Equity Ratio shows it stood at 0.87 in 2024, then increased by 9.17% to 0.79 in 2025, then soared by 223.99% to 0.98 in 2026.
• The last three Equity Ratio figures came in at 0.98 (Q1 2026), 0.79 (Q4 2025), and 0.87 (Q4 2024), per Business Quant data.

Peer Comparison